Literature DB >> 18548286

Improved left ventricular mass index in children after renal transplantation.

Rachel Becker-Cohen1, Amiram Nir, Efrat Ben-Shalom, Choni Rinat, Sofia Feinstein, Benjamin Farber, Yaacov Frishberg.   

Abstract

Left ventricular hypertrophy (LVH) is a risk factor for cardiovascular disease, and it is prevalent in children with end-stage renal disease (ESRD) and after renal transplantation (RTx) on cross-sectional studies. Our aim was to compare prospectively left ventricular mass index (LVMI) in children with ESRD, before and after RTx. Thirteen patients aged 1.5-15 years underwent echocardiogram prior to and at least 3 months after RTx, and again in the second year after transplantation. A control group consisted of children with ESRD who remained on dialysis. Systolic and diastolic blood pressure index decreased significantly over the study period only in the children who had undergone RTx. Mean LVMI in children with ESRD decreased from 45.4 +/- 12.6 g/m(2.7) to 34.9 +/- 10.4 g/m(2.7) after RTx (P = 0.001), but it remained unchanged in patients who remained on dialysis. The prevalence of LVH decreased from 54% to 8% (P = 0.03) after RTx. Systolic and diastolic blood pressure index were correlated with LVMI. Mean body mass index increased during the study period from 17.3 +/- 2.5 to 20 +/- 4.6 (P = 0.05); however, no correlation was found with LVMI. LVH in children with ESRD is potentially reversible after RTx, especially with good control of hypertension.

Entities:  

Mesh:

Year:  2008        PMID: 18548286     DOI: 10.1007/s00467-008-0855-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  20 in total

1.  Changes of blood pressure and left ventricular mass in pediatric renal transplantation.

Authors:  Erwin Kitzmueller; Andreas Vécsei; Judith Pichler; Michael Böhm; Thomas Müller; Regina Vargha; Dagmar Csaicsich; Christoph Aufricht
Journal:  Pediatr Nephrol       Date:  2004-12       Impact factor: 3.714

2.  Changes in left ventricular mass index in children and adolescents after renal transplantation.

Authors:  M M Mitsnefes; S M Schwartz; S R Daniels; T R Kimball; P Khoury; C F Strife
Journal:  Pediatr Transplant       Date:  2001-08

3.  Regression of left ventricular hypertrophy by lisinopril after renal transplantation: role of ACE gene polymorphism.

Authors:  D Hernández; J Lacalzada; E Salido; J Linares; A Barragán; V Lorenzo; L Higueras; B Martín; A Rodríguez; I Laynez; J M González-Posada; A Torres
Journal:  Kidney Int       Date:  2000-08       Impact factor: 10.612

4.  Pronounced renal vasoconstriction and systemic hypertension in renal transplant patients treated with cyclosporin A versus FK 506.

Authors:  J Radermacher; M Meiners; C Bramlage; V Kliem; M Behrend; H J Schlitt; R Pichlmayr; K M Koch; R Brunkhorst
Journal:  Transpl Int       Date:  1998       Impact factor: 3.782

5.  Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight.

Authors:  G de Simone; S R Daniels; R B Devereux; R A Meyer; M J Roman; O de Divitiis; M H Alderman
Journal:  J Am Coll Cardiol       Date:  1992-11-01       Impact factor: 24.094

6.  Echocardiographic changes and risk factors for left ventricular hypertrophy in children and adolescents after renal transplantation.

Authors:  Amr A El-Husseini; Hussein A Sheashaa; Nabil A Hassan; Fawzia M El-Demerdash; Mohamed A Sobh; Mohamed A Ghoneim
Journal:  Pediatr Transplant       Date:  2004-06

7.  Predictors of cardiovascular events in patients with end-stage renal disease: an analysis from the Fosinopril in dialysis study.

Authors:  Michèle Kessler; Faiez Zannad; Philippe Lehert; Jean Pierre Grünfeld; Christian Thuilliez; Alain Leizorovicz; Philippe Lechat
Journal:  Nephrol Dial Transplant       Date:  2007-07-04       Impact factor: 5.992

Review 8.  Molecular insights into uremic cardiomyopathy: cardiotonic steroids and Na/K ATPase signaling.

Authors:  D J Kennedy; D Malhotra; J I Shapiro
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2006-12-30       Impact factor: 1.770

9.  Long-term survival of children with end-stage renal disease.

Authors:  Stephen P McDonald; Jonathan C Craig
Journal:  N Engl J Med       Date:  2004-06-24       Impact factor: 91.245

10.  Abnormal cardiac function in children after renal transplantation.

Authors:  Mark M Mitsnefes; Thomas R Kimball; William L Border; Sandra A Witt; Betty J Glascock; Philip R Khoury; Stephen R Daniels
Journal:  Am J Kidney Dis       Date:  2004-04       Impact factor: 8.860

View more
  14 in total

Review 1.  Cardiovascular disease in children with chronic kidney disease.

Authors:  Mark M Mitsnefes
Journal:  J Am Soc Nephrol       Date:  2012-03-01       Impact factor: 10.121

2.  Kidney transplantation in children with decreased left ventricular systolic function: a Midwest Pediatric Nephrology Consortium study.

Authors:  Sandeep K Riar; Mark M Mitsnefes; Edward J Nehus; Hiren P Patel; Julia M Steinke; Teri Crumb; Elizabeth C Abraham; Margret W Kamel; Larry A Greenbaum
Journal:  Pediatr Nephrol       Date:  2015-03-08       Impact factor: 3.714

3.  Long-term cardiovascular effects of pre-transplant native kidney nephrectomy in children.

Authors:  Marco Cavallini; Giacomo Di Zazzo; Ugo Giordano; Giacomo Pongiglione; Luca Dello Strologo; Nicola Capozza; Francesco Emma; Maria Chiara Matteucci
Journal:  Pediatr Nephrol       Date:  2010-09-25       Impact factor: 3.714

4.  Left ventricular function in children and adults after renal transplantation in childhood.

Authors:  Asle Hirth; Nicola C Edwards; Gottfried Greve; Trine Tangeraas; Eva Gerdts; Kjetil Lenes; Gunnar Norgård
Journal:  Pediatr Nephrol       Date:  2012-04-17       Impact factor: 3.714

Review 5.  Assessment and management of hypertension in transplant patients.

Authors:  Matthew R Weir; Ellen D Burgess; James E Cooper; Andrew Z Fenves; David Goldsmith; Dianne McKay; Anita Mehrotra; Mark M Mitsnefes; Domenic A Sica; Sandra J Taler
Journal:  J Am Soc Nephrol       Date:  2015-02-04       Impact factor: 10.121

6.  FGF23 and Cardiovascular Structure and Function in Advanced Chronic Kidney Disease.

Authors:  Arvin Halim; Heather N Burney; Xiaochun Li; Yang Li; Claudia Tomkins; Andrew M Siedlecki; Tzong-Shi Lu; Sahir Kalim; Ravi Thadhani; Sharon Moe; Stephen M S Ting; Daniel Zehnder; Thomas F Hiemstra; Kenneth Lim
Journal:  Kidney360       Date:  2022-07-05

7.  The impact of kidney transplantation on heart failure risk varies with candidate body mass index.

Authors:  Krista L Lentine; Huiling Xiao; Daniel C Brennan; Mark A Schnitzler; Todd C Villines; Kevin C Abbott; David Axelrod; Jon J Snyder; Paul J Hauptman
Journal:  Am Heart J       Date:  2009-12       Impact factor: 4.749

Review 8.  Cardiovascular disease in CKD in children: update on risk factors, risk assessment, and management.

Authors:  Amy C Wilson; Mark M Mitsnefes
Journal:  Am J Kidney Dis       Date:  2009-08       Impact factor: 8.860

9.  Association and prognostic impact of persistent left ventricular hypertrophy after live-donor kidney transplantation: a prospective study.

Authors:  Hussein Attia Sheashaa; Tarek M Abbas; Nabil A Hassan; Khaled M Mahmoud; Amgad E El-Agroudy; Mohamed A Sobh; Mohamed A Ghoneim
Journal:  Clin Exp Nephrol       Date:  2009-10-31       Impact factor: 2.801

Review 10.  Cardiovascular disease in children with CKD or ESRD.

Authors:  Marc R Lilien; Jaap W Groothoff
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.